An Examination of the Effectiveness of Smoking Cessation Treatment Interventions for Individuals with Severe Mental Illness: A Pilot Randomized Controlled Trial

Overview

Journal Community Ment Health J

Specialty Health Services

Date 2022 Nov 3

PMID 36327043

Authors

Donna Pettey

Jennifer Rae

Tim Aubry

Affiliations

Soon will be listed here.

Abstract

To evaluate the effectiveness of two different smoking cessation interventions for individuals with severe mental illness. Study participants (N = 61) randomly assigned to the SC-R group (n = 29) were offered 24 weeks of no cost Nicotine Replacement Treatment (NRT); participants assigned to the SC + group (n = 32) were offered 24 weeks of no cost NRT plus two initial individual counselling sessions of motivational interviewing and weekly psychosocial group support for 24 weeks. At 6 months the smoking cessation outcome was 7% for the SC-R group and 14% for the SC + group, but there was no statistically significant difference between the groups. Both groups showed a significant decrease in the number of cigarettes smoked per day and significant improvement in physical health functioning. Clients with severe mental illness, high prevalence of co-occurring substance use and experience of homelessness, are both interested and able to quit smoking and reduce cigarette use.

References

Apollonio D, Malone R . Marketing to the marginalised: tobacco industry targeting of the homeless and mentally ill. Tob Control. 2005; 14(6):409-15. PMC: 1748120. DOI: 10.1136/tc.2005.011890. View

Aschbrenner K, Naslund J, Gill L, Hughes T, OMalley A, Bartels S . Qualitative analysis of social network influences on quitting smoking among individuals with serious mental illness. J Ment Health. 2017; 28(5):475-481. PMC: 5876150. DOI: 10.1080/09638237.2017.1340600. View

Ashton M, Rigby A, Galletly C . Evaluation of a community-based smoking cessation programme for people with severe mental illness. Tob Control. 2013; 24(3):275-80. DOI: 10.1136/tobaccocontrol-2013-051179. View

Baggett T, Anderson R, Freyder P, Jarvie J, Maryman K, Porter J . Addressing tobacco use in homeless populations: a survey of health care professionals. J Health Care Poor Underserved. 2013; 23(4):1650-9. DOI: 10.1353/hpu.2012.0162. View

Baggett T, Chang Y, Singer D, Porneala B, Gaeta J, OConnell J . Tobacco-, alcohol-, and drug-attributable deaths and their contribution to mortality disparities in a cohort of homeless adults in Boston. Am J Public Health. 2014; 105(6):1189-97. PMC: 4431083. DOI: 10.2105/AJPH.2014.302248. View

Baker A, Richmond R, Kay-Lambkin F, Filia S, Castle D, Williams J . Randomised controlled trial of a healthy lifestyle intervention among smokers with psychotic disorders: Outcomes to 36 months. Aust N Z J Psychiatry. 2017; 52(3):239-252. DOI: 10.1177/0004867417714336. View

Banham L, Gilbody S . Smoking cessation in severe mental illness: what works?. Addiction. 2010; 105(7):1176-89. DOI: 10.1111/j.1360-0443.2010.02946.x. View

Bero L . Tobacco industry manipulation of research. Public Health Rep. 2005; 120(2):200-8. PMC: 1497700. DOI: 10.1177/003335490512000215. View

Brown C, Leith J, Dickerson F, Medoff D, Kreyenbuhl J, Fang L . Predictors of mortality in patients with serious mental illness and co-occurring type 2 diabetes. Psychiatry Res. 2010; 177(1-2):250-4. PMC: 2866062. DOI: 10.1016/j.psychres.2010.01.004. View

10.

Bryant J, Bonevski B, Paul C, McElduff P, Attia J . A systematic review and meta-analysis of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups. Addiction. 2011; 106(9):1568-85. DOI: 10.1111/j.1360-0443.2011.03467.x. View

11.

Chen L, Baker T, Brownson R, Carney R, Jorenby D, Hartz S . Smoking Cessation and Electronic Cigarettes in Community Mental Health Centers: Patient and Provider Perspectives. Community Ment Health J. 2016; 53(6):695-702. PMC: 5449258. DOI: 10.1007/s10597-016-0065-8. View

12.

Chesher N, Bousman C, Gale M, Norman S, Twamley E, Heaton R . Chronic illness histories of adults entering treatment for co-occurring substance abuse and other mental health disorders. Am J Addict. 2012; 21(1):1-4. PMC: 3629909. DOI: 10.1111/j.1521-0391.2011.00196.x. View

13.

Cornelius M, Loretan C, Wang T, Jamal A, Homa D . Tobacco Product Use Among Adults - United States, 2020. MMWR Morb Mortal Wkly Rep. 2022; 71(11):397-405. PMC: 8942309. DOI: 10.15585/mmwr.mm7111a1. View

14.

Gallagher S, Penn P, Schindler E, Layne W . A comparison of smoking cessation treatments for persons with schizophrenia and other serious mental illnesses. J Psychoactive Drugs. 2008; 39(4):487-97. DOI: 10.1080/02791072.2007.10399888. View

15.

Gatov E, Rosella L, Chiu M, Kurdyak P . Trends in standardized mortality among individuals with schizophrenia, 1993-2012: a population-based, repeated cross-sectional study. CMAJ. 2017; 189(37):E1177-E1187. PMC: 5602497. DOI: 10.1503/cmaj.161351. View

16.

Gilbody S, Peckham E, Bailey D, Arundel C, Heron P, Crosland S . Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial. Lancet Psychiatry. 2019; 6(5):379-390. PMC: 6546931. DOI: 10.1016/S2215-0366(19)30047-1. View

17.

Hall S, Prochaska J . Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings. Annu Rev Clin Psychol. 2009; 5:409-31. PMC: 2718730. DOI: 10.1146/annurev.clinpsy.032408.153614. View

18.

Hawes M, Roth K, Cabassa L . Systematic Review of Psychosocial Smoking Cessation Interventions for People with Serious Mental Illness. J Dual Diagn. 2021; 17(3):216-235. PMC: 8647929. DOI: 10.1080/15504263.2021.1944712. View

19.

Heatherton T, Kozlowski L, Frecker R, Fagerstrom K . The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991; 86(9):1119-27. DOI: 10.1111/j.1360-0443.1991.tb01879.x. View

20.

Horsfall J, Cleary M, Hunt G, Walter G . Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence. Harv Rev Psychiatry. 2009; 17(1):24-34. DOI: 10.1080/10673220902724599. View